secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2025-09-17T23:59:59+00:00
Accession:  0001493152-25-013836
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intelligent Bio Solutions must resubmit FDA 510(k) for drug screening system after new info request
--------------------------------------------------------------------------------

- FDA requested new additional information in a letter dated September 12, 2025, requiring a new 510(k) resubmission.
- Company previously responded to a February 2025 AI request covering over 70 items and submitted additional data in August 2025.
- First-of-its-kind sweat-based device; FDA feedback described as not uncommon for breakthrough technologies.
- Company expects an investor update within ten days outlining a revised timeline for FDA clearance.
- International commercial activities continue to grow outside the U.S. while pursuing clearance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315225013836/0001493152-25-013836-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315225013836/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-013836

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer